| ADT | androgen deprivation therapy |
| LPA | life-prolonging agent |
| mCRPC | metastatic castration resistant prostate cancer |
| mHSPC | metastatic hormone-sensitive prostate cancer |
| PC | prostate cancer |
| piOS | post-infection overall survival |
| piPFS | post-infection progression-free survival |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |